Skip to main content
OpenTrials

Clinical trial condition

Signs and Symptoms, Digestive

Explore clinical trials studying Signs and Symptoms, Digestive. Study availability and eligibility vary by location and protocol.

3,786 public trials 399 recruiting studies
Refine in advanced search Browse all conditions

Signs and Symptoms, Digestive trial results

Completed

A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)

NCT01507194

Conditions
Nausea, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +5 more
Locations
  • Helen Keller Hospital Sheffield, Alabama, United States
  • Precision Trials Phoenix, Arizona, United States
  • Visions Clinical Research Boynton Beach, Florida, United States
  • CAP Anesthesia (St. Elizabeth's Medical Center) Boston, Massachusetts, United States
View Trial Details
Completed

BLI801 Laxative in Constipated Adults

NCT01301781

Conditions
Constipation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +1 more
Locations
  • Advanced Clinical Research Institute Anaheim, California, United States
  • Jupiter Research Jupiter, Florida, United States
  • United Medical Research New Smyrna Beach, Florida, United States
  • Long Island GI Research Group Great Neck, New York, United States
View Trial Details
Completed

Phase II Proof-of-concept Study of APD421

NCT01303978

Conditions
Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations
  • Herlev Hospital Copenhagen, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
  • University Hospital of South Manchester NHS Trust Manchester, United Kingdom
View Trial Details
Completed

A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation

NCT01474499

Conditions
Constipation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +1 more
Locations
  • Southern Medical University - Nanfang Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • The Second Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
View Trial Details
Completed

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

NCT00366834

Conditions
Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
View all 223 locations
View Trial Details

Related conditions